Gym Group在2025年收入增长了8%,这受到减重毒品使用者需求的推动,并计划建造75个新的健身房。 The Gym Group saw 8% revenue growth in 2025, boosted by demand from weight-loss drug users, and plans 75 new gyms.

Gym小组报告说,2025年金融增长强劲,8%的收入增至2.449亿英镑,会员人数增至4%至923 000人,其驱动因素是诸如Mounjaro和Wegovy等减重药物使用者需求增加。 The Gym Group reports strong financial growth in 2025, with 8% revenue rise to £244.9 million and membership up 4% to 923,000, driven by increased demand from users of weight-loss drugs like Mounjaro and Wegovy. 首席执行官威尔·奥尔称这些药物为“顺风”，促进了人们为了保持肌肉和持续效果而增加健身房的次数。 CEO Will Orr cites these medications as a "tailwind," boosting gym visits as people seek to maintain muscle and sustain results. 该公司计划在今后三年内开办75个新的健身房——比以前增加了25个——并发行了1 000万英镑的股票回购。 The company plans to open 75 new gyms over the next three years—25 more than before—and launched a £10 million share buyback. 分析家对业绩持正面看法,列举了增长势头和Zen Z的有力参与。 Analysts view the performance positively, citing growth momentum and strong Gen Z engagement. 全年结果应于3月11日到期。 Full-year results are due March 11.